Products Overview

Publications -

  1. Virella, G., Wohltmann, H., Sagel, J., Lopes-Virella, M.F.L., Phillips, C.B., Kilpatrick, M., and Colwell, J. 1981. Soluble immune complexes in patients with Diabetes Mellitus: Detection and pathological significance. Diabetologia 21: 189-191.
  2. Tsang, K.Y., Fudenberg, H.H., Pan, J.F., Gnagy, M.J., and Bristow, C.L. 1983. An in vitro study on the effects of isoprinosine on immune responses in cancer patients. Int. J. Immunopharm. 5: 481-493.
  3. Bristow, C.L. and Boackle, R.J. 1986. Role for human serum amyloid P component in immune clearance through interaction with C1q and Fabγ. Mol. Immunol. 23: 1045-1052.
  4. Bristow, C.L. and Marchalonis, J.J. 1989. Solid-phase antigen binding by purified immunoproteins from antigen-specific monoclonal T cell hybridomas. Mol. Immunol. 26: 611-624.
  5. Bristow, C.L., Lyford, L.K., Stevens, D.P., and Flood, P.M. 1991. Elastase is a constituent product of T cells. Biochem. Biophys. Res. Comm. 181: 232-239.
  6. Bristow, C.L. and Flood, P.M. 1993. T cell antigen receptor immune complexes demonstrating biologic and proteolytic activity. Int. Immunol. 5: 79-88.
  7. Bristow, C.L., Fiscus, S.A., Flood, P.M., and Arnold, R.R. 1995. Inhibition of HIV-1 by modification of a host membrane protease. Int.Immunol. 7: 239-249.
  8. Kuller, J.A., Katz, V.L., McCoy, M.C., and Bristow, C.L. 1995. Alpha1-antitrypsin deficiency and pregnancy. Am. J. Perinatology 12: 303-305.
  9. Bristow, C.L. 1996. HIV Fusion. Science 273:1642-1643.
  10. Bristow, C.L., Di Meo, F., and Arnold, R.R. 1998. Specific activity of α1proteinase inhibitor in human serum: Application to insulin-dependent diabetes mellitus. Clin. Immunol. Immunopathol.89: 247-259.
  11. Bristow, C.L. 2000. The two principal viremias of HIV. A comparison of viral and host characteristics. In: Human Retroviral Infection: Immunological and Molecular Theories, (ed. H. Friedman, K. Ugen, M. Bendinelli) Plenum Publishing Corp., New York, NY, pp. 1-16.
  12. Bristow, C.L. 2001. Slow human immunodeficiency virus (HIV) infectivity correlated with low HIV coreceptor levels. Clin Diagn. Lab. Immunol. 8: 932-936.
  13. Bristow, C.L., Patel, H., and Arnold, R.R. 2001. Self antigen prognostic for human immunodeficiency virus disease progression. Clin Diagn. Lab. Immunol. 8: 937-942.
  14. Messmer, D., Jacque, J-M., Santisteban, C., Bristow, C., Han, S.-Y., Villamide-Herrera, L., Mehlhop, E., Marx, P.A., Steinman, R.M., Gettie, A. and Pope, M. 2002. Nef uncouples cytokine and chemokine production from phenotypic maturation in dendritic cells. J.Immunol. 169:4172-4182.
  15. Cogswell, P.C., Kashatus, D.F., Keifer, J.A., Guttridge, D.C., Reuther, J.Y., Bristow, C., Roy, S., Nicholson, D.W., Baldwin, A.S. 2002. NF-kappa B and Ikappa B alpha are found in the mitochondria: Evidence for regulation of mitochondrial gene expression by NF-kappaB. J. Biol. Chem. 278:2963-2968.
  16. Bristow, C.L., Mercatante, D.R., and Kole, R. 2003. HIV-1 preferentially binds receptors co-patched with cell surface elastase. Blood 102:4479-4486.
  17. Bristow, C.L., Wolkowicz, R., Trucy, M., Franklin, A., Di Meo, F., Kozlowski, M.T., Winston R., Arnold, R.R. 2008. NFkB signaling, elastase localization, and phagocytosis differ in HIV-1 permissive and non-permissive U937 clones. J. Immunol. 180: 492-499.
  18. Bristow, C.L., Cortes, J., Mukhtarzad R., Trucy, M., Franklin, A., Romberg, V., Winston, R. 2010. α1Antitrypsin therapy increases CD4+ lymphocytes to normal values in HIV-1 patients. In Soluble Factors Mediating Innate Immune Responses to HIV Infection, (ed. M. Alfano). Bentham Science Publishers,
  19. Bristow, C.L., Babayeva, M.A., LaBrunda, M., Mullen, M.P., and Winston, R. 2012. α1Proteinase Inhibitor regulates CD4+ lymphocyte levels and is rate limiting in HIV-1 disease. PLoS ONE 7: e31383.
  20. Bristow, C.L. Babayeva, M.A, Modarresi, R., McArthur, C.P. Kumar, S., Awasom, C., Ayuk, L., Njinda, A., Achu, P., and Winston, R. 2012. The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva. J. Vis. Exp. (63), e3999, DOI: 10.3791/3999.

Copyright 2012 | Alpha-1 Biologics Corporation | All Rights Reserved.
Powered By: Palsoftware